Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Òåðàïèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #106  
Ñòàðûé 03.06.2015, 17:28
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Çäðàâñòâóéòå!
Îòëè÷íûé ðåçóëüòàò.
Çíà÷èò êðîâîòå÷åíèÿ íå áûëè àññîöèèðîâàíû ñ íàðóøåíèÿìè ãåìîñòàçà, à ÷òî êàñàåòñÿ À×ÒÂ,
òî îïèñàíî óâåëè÷åíèå ïðè ïðèåìå èçîòðåòèíîèíà:

Öèòàòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Abstract
Patients with severe acne may need elective/urgent surgical interventions during treatment with isotretinoin and it is critical for the surgeon to consider the possible effects of this medication on coagulation systems. The aim of this study is to determine the changes in prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT) during isotretinoin treatment. PT, aPTT, and INR values of 51 severe acne patients were evaluated during routine pre-treatment biochemical analysis. Only patients with normal values were included in the study. The results of before and after 1 month treatment were compared statistically. There were no statistically significant change in mean alanine aminotranferease (ALT), aspartate aminotransferase (AST), PT, and INR values after treatment. A significant increase in aPTT was detected. The INR values, which are more trusted and safe, showed no difference. Isotretinoin seems to have no effect on these coagulation parameters.
Ïðè âàñêóëèòå, áûëà áû ìèíèìàëüíàÿ àêòèâíîñòü è D-äèìåð ðåçêî ïîâûøàåòñÿ.
×òîáû îêîí÷àòåëüíî ïîñòàâèòü òî÷êó, ñòîèëî áû èñêëþ÷èòü IgA íåôðîïàòèþ,
íî ïîêà íåîáõîäèìî ïðîìîíèòîðèòü ôóíêöèþ ïî÷åê ïî êðåàòèíèíó (ïîâòîðèòü ãäå-òî ÷åðåç 7-10 äíåé) è ïîäñ÷åòó ÑÊÔ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #107  
Ñòàðûé 03.06.2015, 17:53
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Öèòàòà:
Ñîîáùåíèå îò KhasanovMD Ïîñìîòðåòü ñîîáùåíèå
Çäðàâñòâóéòå!
×òîáû îêîí÷àòåëüíî ïîñòàâèòü òî÷êó, ñòîèëî áû èñêëþ÷èòü IgA íåôðîïàòèþ,
íî ïîêà íåîáõîäèìî ïðîìîíèòîðèòü ôóíêöèþ ïî÷åê ïî êðåàòèíèíó (ïîâòîðèòü ãäå-òî ÷åðåç 7-10 äíåé) è ïîäñ÷åòó ÑÊÔ.
Ñïàñèáî áîëüøîå. Ñäàì. Îòïèøóñü.

Îäèí âîïðîñ, åñëè âû íå ïðîòèâ. ß ðåøèë ïîìåíÿòü íåôðîëîãà. Íîâûé ñïåöèàëèñò áîëåå äåìîêðàòè÷íûé, ñëîâà î áèîïñèè íå êàæóòñÿ åìó òàêèìè íåäîïóñòèìûìè (õîòÿ òàêèìè òåìïàìè äî íåå åùå äàëåêî). Îí âûñêàçàë ìíåíèå î âòîðè÷íîì àìèëîèäîçå. ß ïîíèìàþ, ÷òî âû íå âèäèòå ìåíÿ â æèçíè, íî âñå òàêè, âàì ýòà ãèïîòåçà íå êàæåòñÿ òàêîé ýêçîòè÷íîé?
Îòâåòèòü ñ öèòèðîâàíèåì
  #108  
Ñòàðûé 03.06.2015, 18:05
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò PETR9992 Ïîñìîòðåòü ñîîáùåíèå
Ñïàñèáî áîëüøîå. Ñäàì. Îòïèøóñü.

Îäèí âîïðîñ, åñëè âû íå ïðîòèâ. ß ðåøèë ïîìåíÿòü íåôðîëîãà. Íîâûé ñïåöèàëèñò áîëåå äåìîêðàòè÷íûé, ñëîâà î áèîïñèè íå êàæóòñÿ åìó òàêèìè íåäîïóñòèìûìè (õîòÿ òàêèìè òåìïàìè äî íåå åùå äàëåêî). Îí âûñêàçàë ìíåíèå î âòîðè÷íîì àìèëîèäîçå. ß ïîíèìàþ, ÷òî âû íå âèäèòå ìåíÿ â æèçíè, íî âñå òàêè, âàì ýòà ãèïîòåçà íå êàæåòñÿ òàêîé ýêçîòè÷íîé?
ßâíûõ ïðîÿâëåíèé AA àìèëîèäîçà íå îïèñûâàåòå, íî î÷íîìó âðà÷ó âèäíåå.
Ïîñòàðàéòåñü åãî óáåäèòü ëþáûìè äîñòóïíûìè ñïîñîáàìè.
Ìàíèïóëÿöèÿ íå ñëîæíàÿ, íî î÷åíü òÿæåëî ìîòèâèðîâàòü íåôðîëîãîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #109  
Ñòàðûé 03.06.2015, 18:28
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Öèòàòà:
Ñîîáùåíèå îò KhasanovMD Ïîñìîòðåòü ñîîáùåíèå
Ïîñòàðàéòåñü åãî óáåäèòü ëþáûìè äîñòóïíûìè ñïîñîáàìè.
Áîëüøå íå îñòàëîñü íèêàêèõ ñïîñîáîâ ýòî ñäåëàòü? Èëè óæå ìîæíî íà÷èíàòü íà æàëîñòü äàâèòü?)
Îòâåòèòü ñ öèòèðîâàíèåì
  #110  
Ñòàðûé 03.06.2015, 18:31
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò PETR9992 Ïîñìîòðåòü ñîîáùåíèå
Áîëüøå íå îñòàëîñü íèêàêèõ ñïîñîáîâ ýòî ñäåëàòü? Èëè óæå ìîæíî íà÷èíàòü íà æàëîñòü äàâèòü?)
Íå çàáóäüòå ïîâòîðèòü êðåàòèíèí
Îòâåòèòü ñ öèòèðîâàíèåì
  #111  
Ñòàðûé 03.06.2015, 18:38
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #112  
Ñòàðûé 09.06.2015, 21:38
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Äîáðîå âðåìÿ ñóòîê, Óìàð Âëàäèìèðîâè÷. Ïîëó÷èëîñü íà íåñêîëüêî äíåé ðàíüøå, åñëè ýòî íå êðèòè÷íî.

Ïàðàìåòðû 25 àâãóñòà 28 îêòÿáðÿ 2014 27 íîÿáðÿ25 ÿíâàðÿ (â îòäåëåíèè íåôðîëîãèè) 8 àïðåëÿ 8 ìàÿ28 ìàÿ 9 èþíÿ
êðåàòèíèí 5458.5umol/L (62-115)7076 70 85.56664
îáùèé áåëîêõ 70 ã/ë (64-83) 65.3 73.5 76
K Na Cl   Ê- 3.39, Na- 137 Cl- 99  Ê- 4.32, Na- 149 Cl- 105 Ê- 3.77, Na- 147 Cl- 104
Ìî÷åâèíà 2.5 2.7 mmol/L (0-8.3)4.12.5  3.6 4.2
Ìî÷åâàÿ êèñëîòà 313    227 296
Àëüáóìèí     52.3 ã/ë 50.8
Ñóòî÷íàÿ ïðîòåèíóðèÿ      300ìã/äåíü  
ÑÐÐ    0.18   1.04
ÑÊÔ mL/min/1.73m2 141,7137,1127,3123,1 127,3 111 130140

Åñëè êðàòêî, ñêàæó òàê:
1) Êóðàíòèë íå ïüþ óæå ìåñÿö, ñ òåõ ïîð êàê ñäàâàë àíàëèç íà áåëîê Áåíñ-Äæîíñà.
2)ÎÀÌ íåïîíÿòíûì îáðàçîì ñòàë ÷èñòûì. Áåëêà íåò. Èñõîäÿ èç ýòîãî, äàæå ìîé íîâûé âðà÷ ìûñëü î áèîïñèè âèäèò íåäîïóñòèìîé, èëè õîòÿ áû ïðåæäåâðåìåííîé. Ê ñîæàëåíèþ, îí íåïîêîëåáèì, òàê êàê àíàëèç ÷èñòûé ïî÷åìó òî è ÁÕ "íîðìàëüíàÿ".

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
ÎÀÊ (ñîý 3)

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Áèîõèìèÿ(+õîëåñòåðèí è áèëëèðóáèí ñ ôðàêöèÿìè)

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
ÎÀÌ (÷èñòûé)

Îäèí âîïðîñ, åñëè âû íå ïðîòèâ. Ïî êàêîé ôîðìóëå ìíå ðàñ÷èòûâàòü ÑÊÔ? Êàêàÿ áîëåå òî÷íàÿ?
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ï.Ñ.: ò.ê. ÿ îêîí÷èë óíèâåðñèòåò, ìåíÿ ïðèçûâàþò â àðìèþ ýòîé îñåíüþ. Çíàÿ, êàê ðàáîòàåò íàøà âîåííàÿ êîìèññèÿ(â ïðîøëîì ãîäó îòïðàâèëè äðóãà è ïðîñìîòðåëè ÿçâó æåëóäêà, óåõàë â ðåàíèìàöèþ ÷åðåç 2 íåäåëè) ÿ ïîíèìàþ, ÷òî ñî ìíîé öåðåìîíèòñÿ íå áóäóò è ñêîðåé âñåãî îòïðàâÿò. Åñòü ëè êàêèå òî ïîäâîäíûå êàìíè?

Áëàãîäàðþ çà ïîìîùü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #113  
Ñòàðûé 09.06.2015, 22:30
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïàðàìåòðû 25 àâãóñòà 28 îêòÿáðÿ 2014 27 íîÿáðÿ25 ÿíâàðÿ 8 àïðåëÿ 8 ìàÿ 28 ìàÿ 9 èþíÿ
êðåàòèíèí 54 58.5 70 76 70 85,5 66 64
ÑÊÔ mL/min/1.73m2 141,7137,1127,3123,1 127,3 111 130 131

[Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì]

Âàñêóëèòû ïðîòåêàþò áîëåå àãðåññèâíî, à çäåñü ïîëîæèòåëüíàÿ äèíàìèêà ïðàêòè÷åñêè ïðè îòñóòñòâèè êàêîãî-ëèáî ëå÷åíèÿ.

Çàî÷íî ñëîæíî äåëàòü âûâîäû, íî ñêîðåå âñåãî ñîñòîÿíèå áûëî ñâÿçàíî ñ ïîáî÷íûìè ýôôåêòàìè ïðåïàðàòà.

Ñóäÿ ïî óðîâíþ ãåìîãëîáèíà, ôåððèòèí ñêîðåå âñåãî óæå ìåíüøå 40 è ïîòðåáóåòñÿ ïðîôèëàêòè÷åñêèé ïðèåì ïðåïàðàòîâ æåëåçà - ñòîèò ïðîâåðèòü.

ß ïîëüçóþñü ýòèì êàëüêóëÿòîðîì:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Äîñòóïåí ïîäïèñ÷èêàì UpToDate, íî íàâåðíÿêà åñòü â áåñïëàòíîì äîñòóïå.

Åäèíñòâåííîå, ÷òî íå ïîíÿòíî - ïî÷åìó òàê "áóðíî" îòðåàãèðîâàëè íà èçîòðåòèíîèí.
Ïîýòîìó ðàññïðàøèâàë ïðî ïèùåâûå ïðèñòðàñòèÿ è ò.ä.

Ïîçäðàâëÿþ Âàñ ñ îêîí÷àíèåì ÂÓÇà!
Îòâåòèòü ñ öèòèðîâàíèåì
  #114  
Ñòàðûé 09.06.2015, 22:46
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Öèòàòà:
Ñîîáùåíèå îò KhasanovMD Ïîñìîòðåòü ñîîáùåíèå
Âàñêóëèòû ïðîòåêàþò áîëåå àãðåññèâíî, à çäåñü ïîëîæèòåëüíàÿ äèíàìèêà ïðàêòè÷åñêè ïðè îòñóòñòâèè êàêîãî-ëèáî ëå÷åíèÿ.
Çàî÷íî ñëîæíî äåëàòü âûâîäû, íî ñêîðåå âñåãî ñîñòîÿíèå áûëî ñâÿçàíî ñ ïîáî÷íûìè ýôôåêòàìè ïðåïàðàòà.
Åäèíñòâåííîå, ÷òî íå ïîíÿòíî - ïî÷åìó òàê "áóðíî" îòðåàãèðîâàëè íà èçîòðåòèíîèí.
Ïîçäðàâëÿþ Âàñ ñ îêîí÷àíèåì ÂÓÇà!
Ñïàñèáî çà ïðèÿòíûå ïîçäðàâëåíèÿ
Äàëüøå ïðîñòî íàáëþäàòüñÿ?
Âñå òàêè áîëüøèíñòâî æàëîá òî íà ìåñòå)

Åñëè âñå òàê, êàê âû ãîâîðèòå, òî ïîëó÷àåòñÿ, ÷òî âñå ïðîéäåò ñî âðåìåíåì, ýòî ïðèÿòíî ñëûøàòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #115  
Ñòàðûé 09.06.2015, 22:52
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò PETR9992 Ïîñìîòðåòü ñîîáùåíèå
Âñå òàêè áîëüøèíñòâî æàëîá òî íà ìåñòå)
Ñóäÿ ïî îáùåìó àíàëèçó êðîâè, êàê è äåôèöèò æåëåçà.
Ïðîâåðüòå ñåé÷àñ ôåððèòèí, à ÷åðåç 3-4 íåäåëè êðåàòèíèí.
Îòâåòèòü ñ öèòèðîâàíèåì
  #116  
Ñòàðûé 09.06.2015, 22:59
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Öèòàòà:
Ñîîáùåíèå îò KhasanovMD Ïîñìîòðåòü ñîîáùåíèå
Ñóäÿ ïî îáùåìó àíàëèçó êðîâè, êàê è äåôèöèò æåëåçà.
Ïðîâåðüòå ñåé÷àñ ôåððèòèí, à ÷åðåç 3-4 íåäåëè êðåàòèíèí.
Õîðîøî. Îòïèøóñü.
Ñïàñèáî âàì áîëüøîå è, åñëè ÷åñòíî, òî çàî÷íî âû âíèêëè â ìîþ ñèòóàöèþ ãîðàçäî ãëóáæå, ÷åì î÷íî áîëüøèíñòâî âñòðå÷àâøèõñÿ ìíå âðà÷åé çà ýòè 10 ìåñÿöåâ, ÷òî î÷åíü ñòðàííî. Åùå ðàç ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #117  
Ñòàðûé 09.06.2015, 23:23
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ê ñîæàëåíèþ, âîçìîæíîñòè èíòåðíåò êîíñóëüòèðîâàíèÿ îãðàíè÷åíû.
Áûëî áû ãîðàçäî ïðîùå åñëè áû ñïåöèàëèñòû íå áîÿëèñü ïðîâîäèòü äîñòàòî÷íî ðóòèííûå ìåòîäû èññëåäîâàíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #118  
Ñòàðûé 15.06.2015, 12:35
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Çäðàâñòâóéòå!
À ÷òî áûëî â íà÷àëå ìàÿ?
Áûëè ëè êàêèå-ëèáî èçìåíåíèÿ â ñîñòîÿíèè, ïðåïàðàòû?
Îòâåòèòü ñ öèòèðîâàíèåì
  #119  
Ñòàðûé 15.06.2015, 18:03
PETR9992 PETR9992 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.09.2014
Ãîðîä: ã. Îêòÿáðüñêèé, Ðåñïóáëèêà Áàøêîðòîñòàí
Ñîîáùåíèé: 96
PETR9992 *
Öèòàòà:
Ñîîáùåíèå îò KhasanovMD Ïîñìîòðåòü ñîîáùåíèå
Çäðàâñòâóéòå!
À ÷òî áûëî â íà÷àëå ìàÿ?
Áûëè ëè êàêèå-ëèáî èçìåíåíèÿ â ñîñòîÿíèè, ïðåïàðàòû?
Äîáðûé äåíü, Óìàð Âëàäèìèðîâè÷.

ß ìàëî åë â òî âðåìÿ è çà íåñêîëüêî ìåñÿöåâ äî ýòîãî (ìàÿ), òàê êàê ñåìåñòð â âóçå áûë î÷åíü ýìîöèîíàëüíî è ôèçè÷åñêè òÿæåëûé, ÿ òîëêîì íè÷åãî íå óñïåâàë, ïåðåêóñûâàë ÷åì ïîïàëî, èíîãäà åë äàæå îäèí ðàç â äåíü.  îñòàëüíîì êàêèõ òî îñîáåííîñòåé ñâîåãî ñîñòîÿíèÿ â òîò ìîìåíò íå îòìå÷àþ.

Íó è â íà÷àëå ìàÿ ìåíÿ íà÷àë áåñïîêîèòü êîìîê â ãîðëå ãäå òî ïîä êàäûêîì, î÷åíü ñèëüíî, òî ïðîõîäèë, òî ïîÿâëÿëñÿ, â îñòàëüíîì ÷óâñòâîâàë ñåáÿ íîðìàëüíî, ïîòîì ïîñòåïåííî, óæå ëåòîì, íà÷àëà ïîÿâëÿòüñÿ êðîâîòî÷èâîñòü, ïëîõîé çàïàõ, íàëåòû æåëòûå íà ÿçûêå, íà÷àëî áîëåòü â ãðóäè ïðè âäîõå, à óæå áëèæå ê îñåíè íà÷àëà ïðûãàòü òåìïåðàòóðà è òîãäà óæå ÿ êîíêðåòíî çàëèõîðàäèë.

Ïðèíèìàë òîëüêî àêíåêóòòàí ïî 16 ìã/äåíü (äî ñåíòÿáðÿ).

Ï.Ñ.: àíàëèçû áóäóò çàâòðà.

Áëàãîäàðþ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #120  
Ñòàðûé 15.06.2015, 20:31
Àâàòàð äëÿ KhasanovMD
KhasanovMD KhasanovMD âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.11.2013
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 1,089
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 479 ðàç(à) çà 417 ñîîáùåíèé
KhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKhasanovMD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èìåþ ââèäó ìàé ýòîãî ãîäà.
Ñóäÿ ïî ãðàôèêó èäåò óëó÷øåíèå âûäåëèòåëüíîé ôóíêöèè ïî÷åê
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 16:14.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.